| 1 |
Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta[J]. Blood, 1990,75(11):2213-2219.
|
| 2 |
刘朵平，田卫伟，马梁明，等. 肝脾T细胞淋巴瘤诊治进展[J/CD]. 中华临床医师杂志(电子版), 2017,11(1):127-131.
|
| 3 |
蒲业迪，李颢，李湘新，等. 肝脾γδT细胞淋巴瘤一例并文献复习[J]. 白血病·淋巴瘤, 2013,22(3):179-180.
|
| 4 |
Madabhavi I, Modi G, Panchal H, et al. Hepatosplenic gamma delta T-cell lymphoma (HSGDTCL): two rare case reports from western India[J]. Int J Hematol Oncol Stem Cell Res, 2017,11(4):296-300.
|
| 5 |
Thai A, Prindiville T. Hepatosplenic T-cell lymphoma and inflammatory bowel disease[J]. J Crohns Colitis, 2010,4(5):511-522.
|
| 6 |
Yabe M, Miranda RN, Medeiros LJ. Hepatosplenic T-cell lymphoma: a review of clinicopathologic features, pathogenesis and prognostic factors[J]. Hum Pathol, 2018,74:5-16.
|
| 7 |
Deepak P, Sifuentes H, Sherid M, et al. T-cell non-Hodgkin′s lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-alpha) inhibitors: results of the REFURBISH study[J]. Am J Gastroenterol, 2013,108(1):99-105.
|
| 8 |
Hassan R, Franco SA, Stefanoff CG, et al. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections[J]. Pathol Int, 2006,56(11):668-673.
|
| 9 |
Ohshima K, Haraoka S, Harada N, et al. Hepatosplenic gammadelta T-cell lymphoma: relation to Epstein-Barr virus and activated cytotoxic molecules[J]. Histopathology, 2000,36(2):127-135.
|
| 10 |
Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990[J]. Leukemia, 2000,14(6):991-997.
|
| 11 |
Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients[J]. Blood, 2003,102(13):4261-4269.
|
| 12 |
Chernova NG, Julhakyan HL, Vinogradova YE, et al. Hepatosplenic T-cell lymphoma: The problems of diagnosis and treatment[J]. Ter Arkh, 2016,88(7):4-14.
|
| 13 |
刘恩彬，陈辉树，杨晴英，等. 肝脾T细胞淋巴瘤的脾、肝及骨髓病理形态学观察[J]. 诊断病理学杂志, 2005,12(1):65-66.
|
| 14 |
Calvaruso M, Gulino A, Buffa S, et al. Challenges and new prospects in hepatosplenic gammadelta T-cell lymphoma[J]. Leuk Lymphoma, 2014,55(11):2457-2465.
|
| 15 |
Visnyei K, Grossbard ML, Shapira I. Hepatosplenic gammadelta T-cell lymphoma: an overview[J]. Clin Lymphoma Myeloma Leuk, 2013,13(4):360-369.
|
| 16 |
Travert M, Huang Y, de Leval L, et al. Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets[J]. Blood, 2012,119(24):5795-5806.
|
| 17 |
Gumbs AA, Zain J, Neylon E, et al. Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia[J]. Ann Surg Oncol, 2009,16(7):2014-2017.
|
| 18 |
Durani U, Go RS. Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States[J]. Am J Hematol, 2017,92(6):E99-E101.
|
| 19 |
Jaeger G, Bauer F, Brezinschek R, et al. Hepatosplenic gammadelta T-cell lymphoma successfully treated with a combination of alemtuzumab and cladribine[J]. Ann Oncol, 2008,19(5):1025-1026.
|
| 20 |
Voss MH, Lunning MA, Maragulia JC, et al. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience[J]. Clin Lymphoma Myeloma Leuk, 2013,13(1):8-14.
|
| 21 |
Rashidi A, Cashen AF. Outcomes of allogeneic stem cell transplantation in hepatosplenic T-cell lymphoma[J]. Blood Cancer J, 2015,5:e318.
|